Skip to main content

Palo Alto Investors LP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1306923 PALO ALTO, CA

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,386,733
-$182,801 QoQ
Shares Held
18,117
0.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Palo Alto Investors LP holds $48,813,712 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (4.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
18,117 $2,386,733

All Filings in NBIX

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,386,733 18,117
2025-12-31 $2,569,534 18,117
2025-09-30 $2,543,264 18,117
2025-06-30 $1,675,950 13,334
2025-03-31 $1,474,740 13,334